CTCL

Bexarotene for CTCL | Therapeutic Cheat Sheet
Bexarotene for CTCL
by Adrianna Gonzalez Lopez, MD on
Cutaneous T cell lymphoma (CTCL) is the most common primary cutaneous lymphoma, and in some patients, it could be persistent for decades. Therapy for CTCL depends on disease stage and response to prior treatments. In this month’s installment of Therapeutic Cheat Sheets, we will discuss use of bexarotene for the treatment of CTCL. BEXAROTENE THERAPEUTIC CHEAT SHEET Compiled by: Adrianna Gonzale …

Continue reading "Bexarotene for CTCL | Therapeutic Cheat Sheet"

Patient Buzz: Misdiagnosed Skin Conditions
Differential diagnosis
by Allison Sit on
Women’s Health recently wrote an article about four skin conditions that are commonly misdiagnosed. Why do primary care providers sometimes misdiagnose common skin conditions? What conditions are challenging for dermatologists to diagnose? What steps can a dermatologist take to make a differential diagnosis? For expert advice, I contacted Steve Daveluy, MD, FAAD, associate professor and pr …

Continue reading "Patient Buzz: Misdiagnosed Skin Conditions"

Widespread Skin Necrosis Secondary to Gemcitabine Therapy
Skin Necrosis
by NEXT STEPS IN DERM TEAM on
INTRODUCTION Cutaneous side effects are relatively common in chemotherapy but vary in frequency and severity depending on the medication, dose, duration, pharmacokinetics, and pharmacodynamics. Gemcitabine, a pyrimidine nucleoside analogue, is a common oncologic agent used in the treatment of a variety of malignancies such as cancers of the head and neck, lung cancer, breast cancer, pancreatic …

Continue reading "Widespread Skin Necrosis Secondary to Gemcitabine Therapy"

Dupilumab Treatment for Prurigo Nodularis and Pruritis
Prurigo Nodularis
by NEXT STEPS IN DERM TEAM on
Authors Ross Tanis MD MS, Katalin Ferenczi MD, and B Michael Payette MD MBAB present a case where they demonstrated that treatment of Prurigo Nodularis (PN) with dupilumab significantly decreased pruritis and the size and number of new lesions after 2 months of treatment. INTRODUCTION Prurigo nodularis is an intensely pruritic skin disease in which dome-shaped papulonodules result from chroni …

Continue reading "Dupilumab Treatment for Prurigo Nodularis and Pruritis"